Utbildningar migrän


Informationsvideo om neurologiska sjukdomar under COVID-19 pandemin (SARS-CoV-2)

Dr. Sahin, Ph.D. Skåneuro AB och Dr. Özkaya Sahin, Ph.D. Lunds Universitetssjukhus

Insights into Sleep Habits, Sleep Disorders and Headache Disorders

Dr Baruch El-Ad, Neurology and Sleep Medicine, Tel Aviv-Yafo, Israel

Calcitonin gene-related protein (CGRP) in peripheral and central sensitisation

Anthony Dickenson, Professor, University College London, UK

Epidemiology, clinical manifestations and the burden of disease

Mattias Linde, MD, PhD, Professor

Preventive treatment of migraine, now and in the future

Lars Bendtsen, MD, PhD, Dr Med Sci

Disease mechanisms and treatment targets

Lars Edvinsson, MD, PhD, Professor

European Headache Federation guideline on the use of calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) for migraine prevention

Lars Bendtsen, MD, PhD, Dr Med Sci

Scientific meetings

Migraine management

Anti-CGRPs, from Molecule to Man

This meeting was held in Copenhagen, 29-30 november 2019
Brief summary from the migraine symposium

TEVA Nordics has since 2013 arranged an annual scientific symposium within multiple sclerosis intended to be complementary to other international congresses and with highest clinical and scientific relevance. 

These symposia continue within the field of migraine having top international migraine experts in the steering committee and as speakers. We strive to provide the speakers an opportunity to present their work/research in an environment facilitating interactions and discussions.

The topics and speakers have been selected by a Steering Committee consisting of leading migraine experts from each Nordic country.
If you have any questions regarding these symposiums, please contact your local Teva medical representative in Sweden: Fredrik Blomstrand / fredrik.blomstrand@teva.se
Senast uppdaterad 10 juni 2020

Arbetar du inom vårdsektorn?

Om du är sjukvårdspersonal har du tillgång till läkemedelsinformation som 
är riktad endast till vården.